CF102 for the treatment of hepatocellular carcinoma: A phase I/II, open-label, dose-escalation study.

被引：0
|
作者：
Stemmer, Salomon M.
Benjaminov, Ofer
Medalia, Gal
Ciuraru, Noa
Silverman, Michael H.
Bar Yehuda, Sara
Fishman, Sari
Harpaz, Zivit
Farbstein, Motti
Cohen, Shira
Petoka, Renana
Singer, Barak
Kerns, William D.
Fishman, Pnina
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Canfite, Petah Tiqwa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14731
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I, open-label, multi-center, dose-escalation study of codrituzumab, an anti-glypican-3 monoclonal antibody, in combination with atezolizumab in patients with locally advanced or metastatic hepatocellular carcinoma
    Cheng, A-L.
    Yen, C-J.
    Okusaka, T.
    Ikeda, M.
    Hsu, C-H.
    Wu, S-Y.
    Morizane, C.
    Hashimoto, Y.
    Ueshima, K.
    Ohtomo, T.
    Tanaka, T.
    Kudo, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [42] An Open-Label, Sequential Dose-Escalation, Safety, and Tolerability Study of Rimabotulinumtoxinb in Subjects With Cervical Dystonia
    Chinnapongse, Robert
    Pappert, Eric J.
    Evatt, Marian
    Freeman, Alan
    Birmingham, William
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (11) : 703 - 710
  • [43] Open-label, Dose-escalation Study of L-glucose as a Bowel Preparation Before Colonoscopy
    Balaban, David
    Riff, Dennis
    Schwab, Robert
    Thompson, William
    McNamara, Sherrie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S502 - S503
  • [44] Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders - An open-label, dose-escalation study
    Findling, Robert L.
    Kauffman, Ralph E.
    Sallee, Floyd R.
    Carson, William H.
    Nyilas, Margaretta
    Mallikaarjun, Suresh
    Shoaf, Susan E.
    Forbes, Robert A.
    Boulton, David W.
    Pikalov, Andrei
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (04) : 441 - 446
  • [45] An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer
    Liu, Joyce
    Burris, Howard
    Wang, Judy S.
    Barroilhet, Lisa
    Gutierrez, Martin
    Wang, Yulei
    Vaze, Anjali
    Commerford, Renee
    Royer-Joo, Stephanie
    Choeurng, Voleak
    Humke, Eric
    Moore, Kathleen
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 163 (03) : 473 - 480
  • [46] An Open-label Dose-escalation Study of BIBF 1120 in Patients with Relapsed or Refractory Multiple Myeloma
    Kropff, Martin
    Kienast, Joachim
    Bisping, Guido
    Berdel, Wolfgang E.
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    Stefanic, Martin
    Munzert, Gerd
    [J]. ANTICANCER RESEARCH, 2009, 29 (10) : 4233 - 4238
  • [47] Trial in progress: A phase I/II, open-label, dose-escalation, safety and tolerability study of NC318 in subjects with advanced or metastatic solid tumors.
    Gutierrez, Martin
    Hamid, Omid
    Shum, Elaine
    Wise, David R.
    Balar, Arjun Vasant
    Weber, Jeffrey S.
    LoRusso, Patricia
    Shafi, Saba
    Rimm, David L.
    Tolcher, Anthony W.
    Basudhar, Debashree
    Dujka, Melanie Elizabeth
    Heller, Kevin N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Neuromuscular effect of dexmedetomidine on sevoflurane: an open-label, dose-escalation clinical trial
    Ke, Hui-Hua
    Wu, Huang-Hui
    Zhu, Qi
    Zhang, Yan
    Xiao, Jin-Rong
    Su, Xiu-Zhu
    Zheng, Wan-Jing
    Cai, Yu-Ping
    Wu, Xiao-Zhi
    Wang, Yu-Tong
    Chen, Guo-Zhong
    [J]. MINERVA ANESTESIOLOGICA, 2017, 83 (08) : 790 - 797
  • [49] A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer
    Kazmi, Farasat
    Nicum, Shibani
    Roux, Rene L.
    Spiers, Laura
    Gnanaranjan, Chat
    Sukumaran, Ajithkumar
    Gabra, Hani
    Ghazaly, Essam
    McCracken, Nigel W.
    Harrison, David J.
    Blagden, Sarah P.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3028 - 3038
  • [50] A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
    du Bois, A.
    Huober, J.
    Stopfer, P.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Reichardt, V. L.
    Harter, P.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (02) : 370 - 375
12345